Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug ...

Haemonetics Gets FDA Clearance for Next-Gen Plasma Collection System

Haemonetics received clearance from the Food and Drug Administration for its next-generation plasma collection system. The medical technology company said Monday that the FDA granted 510(k) clearance ...
Business Insider

Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology

BRAINTREE, Massachusetts, March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its ...
Seeking Alpha

Haemonetics Receives FDA Clearance for Enhancements to NexSys PCS® Plasma Collection System

BOSTON, June 22, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it ...